Lactobacillus acidophilus potentiates oncolytic virotherapy through modulating gut microbiota homeostasis in hepatocellular carcinoma

Oncolytic viruses (OVs) hold promise for cancer treatment. However, the antitumor efficacy is limited. Microbiota plays a pivotal role in cancer treatment and its impact on oncolytic virotherapy is unknown. Here, we show that VSVΔ51 has higher antitumor efficacy for hepatocellular carcinoma in the absence of microbiota in female mouse models. VSVΔ51 infection causes microbiota dysbiosis, increasing most of the gut bacteria abundance, while decreasing the commensal Lactobacillus. VSVΔ51 reduced intestinal expression of SLC20A1 that binds to Lactobacillus acidophilus (L. acidophilus) CdpA cell wall protein through IL6-JAK-STAT3 signaling, thereby attenuating attachment and colonization of L. acidophilus. L. acidophilus supplementation confers sensitivity to VSVΔ51 through restoring gut barrier integrity and microbiota homeostasis destroyed by VSVΔ51. In this work, we show that targeting microbiota homostasis holds substantial potential in improving therapeutic outcomes of oncolytic virotherapy.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-04-07
DOI
https://doi.org/10.1038/s41467-025-58407-z
Citations
11
Primary Topic
Virus-based gene therapy research
Type
article
Field-Weighted Citation Impact
19.99
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lactobacillus acidophilus potentiates oncolytic virotherapy through modulating gut microbiota homeostasis in hepatocellular carcinoma

Haidan Luo, Dean W. Felsher, Baifu Qin, Yijing Zhang et al.
11 citations
Nature Communications
Virus-based gene therapy research
19.99
article

Lactobacillus acidophilus potentiates oncolytic virotherapy through modulating gut microbiota homeostasis in hepatocellular carcinoma

Haidan Luo, Dean W. Felsher, Baifu Qin, Yijing Zhang, Mong‐Hong Lee, W. Wu, Kai Li, Ping Yuan, Wenxia Wei, Jinyan Luo, Jinneng Yang, Tao Zuo, Haiwen Lyu, Vishnu P Kanakaveti, Jiayu Zhang, Yuzhi Wang, Haipeng Zhang, Runxiang Yang, Zong-Min Fan, H K Lyu, Hairong Yi
article en
11 citations

Abstract

Oncolytic viruses (OVs) hold promise for cancer treatment. However, the antitumor efficacy is limited. Microbiota plays a pivotal role in cancer treatment and its impact on oncolytic virotherapy is unknown. Here, we show that VSVΔ51 has higher antitumor efficacy for hepatocellular carcinoma in the absence of microbiota in female mouse models. VSVΔ51 infection causes microbiota dysbiosis, increasing most of the gut bacteria abundance, while decreasing the commensal Lactobacillus. VSVΔ51 reduced intestinal expression of SLC20A1 that binds to Lactobacillus acidophilus (L. acidophilus) CdpA cell wall protein through IL6-JAK-STAT3 signaling, thereby attenuating attachment and colonization of L. acidophilus. L. acidophilus supplementation confers sensitivity to VSVΔ51 through restoring gut barrier integrity and microbiota homeostasis destroyed by VSVΔ51. In this work, we show that targeting microbiota homostasis holds substantial potential in improving therapeutic outcomes of oncolytic virotherapy.

Nature CommunicationsVol. 16(1)
Sun Yat-sen University (CN), Jinan University (CN), Kunming Medical University (CN), Sixth Affiliated Hospital of Sun Yat-sen University (CN), Jiangsu Province Hospital (CN), Nanjing Medical University (CN), Stanford University (US)
Zero hunger
Openalex Percentile: Top 1%
Virus-based gene therapy research
19.99
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.